Everolimus Tablet Manufacturer, Exporter and Global Supplier in India

Everolimus Tablet Manufacturer, as a trusted we ensure our formulations adhere strictly to WHO-GMP guidelines and international pharmacopeia standards. Each batch undergoes rigorous quality testing for purity, stability, and efficacy, ensuring healthcare providers and patients worldwide receive medicines they can rely on. Everolimus Tablet is a targeted therapy medication widely used in oncology and transplant medicine. Belonging to the class of mTOR (mammalian target of rapamycin) inhibitors, Everolimus works by blocking specific proteins that regulate cell growth, survival, and angiogenesis. By disrupting these pathways, it slows down tumor progression and prevents organ rejection in transplant patients. Because of its dual role in cancer care and immunosuppression, Everolimus Tablet is regarded as one of the most essential modern therapeutic options.

Uses of Everolimus Tablet

• Oncology Applications:

  • Advanced kidney cancer (renal cell carcinoma)

  • Hormone receptor-positive, HER2-negative breast cancer

  • Neuroendocrine tumors of the pancreas, lung, or gastrointestinal tract

  • Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex

• Transplant Medicine:

  • Used as an immunosuppressant to prevent organ rejection in kidney and liver transplant recipients.

With such wide-ranging clinical applications, the role of a reliable Everolimus Tablet Manufacturer becomes vital in meeting global healthcare demands.

Precautions for Everolimus Tablet

• Everolimus must only be taken under strict supervision of an oncologist or transplant specialist.

• Regular monitoring of blood counts, kidney, and liver functions is essential.

• Patients should avoid live vaccines during therapy due to suppressed immunity.

• Grapefruit and grapefruit juice should be avoided as they may interfere with drug metabolism.

• Pregnant or breastfeeding women should not take Everolimus as it may harm the baby.

• Dosage should be tailored to the patient’s condition, medical history, and concurrent therapies.

Being a responsible Everolimus Tablet Manufacturer, we highlight the importance of patient education and medical supervision to minimize risks and ensure treatment success.

Side Effects of Everolimus Tablet

Like most strong therapies, Everolimus may cause side effects that vary depending on dosage and duration of treatment. Common side effects include:

• Mouth ulcers or stomatitis

• Fatigue and weakness

• Rash or skin irritation

• Loss of appetite and weight loss

• Diarrhea or nausea

• Swelling in hands or feet

• Increased susceptibility to infections

Serious but less common side effects include lung inflammation (non-infectious pneumonitis), severe infections, and kidney dysfunction. Patients must immediately inform their healthcare provider if they notice persistent fever, breathing difficulty, or unusual bleeding. As a dedicated Everolimus Tablet Manufacturer, we ensure that product information sheets and safety guidelines are always included with every pack.

Why Choose Us as Your Everolimus Tablet Manufacturer?

As a globally recognized Everolimus Tablet Manufacturer, we are committed to delivering high-quality, reliable, and affordable oncology and transplant medicines. Our advanced production facilities are WHO-GMP certified, and every product undergoes stringent quality assurance before reaching patients.

We serve hospitals, pharmacies, distributors, and healthcare professionals across India and international markets, ensuring timely supply and consistent quality. Our mission is to support global healthcare by making advanced medicines like Everolimus Tablets accessible to those who need them most.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Everolimus Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.